+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anti-Aging Drugs Global Market Report 2024

  • PDF Icon

    Report

  • 200 Pages
  • January 2024
  • Region: Global
  • The Business Research Company
  • ID: 5850420
The anti-aging drugs market has grown strongly in recent years. It will grow from $53.76 billion in 2023 to $57.85 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth observed in the historical period can be attributed to several factors, including the increase in chronic diseases associated with aging, a growing awareness of aging-related health issues, regulatory support for aging research, and a consumer focus on wellness and longevity. These factors collectively contributed to the development and adoption of anti-aging drugs during this period.

The anti-aging drugs market is expected to see strong growth in the next few years. It will grow to $77.85 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The anticipated growth in the forecast period can be attributed to several factors, including the adoption of precision medicine approaches, the emergence of senolytic drugs, increased collaboration and partnerships in research, establishment of regulatory pathways for aging therapeutics, and a growing consumer adoption of anti-aging interventions. Noteworthy trends expected in the forecast period include the development of targeted therapies and personalized medicine, the use of senolytic drugs to address cellular senescence, advancements in gene therapy and CRISPR technologies, a focus on mitochondrial health, and the modulation of the microbiome for longevity.

The growth of the anti-aging drugs market is anticipated to be fueled by the increasing aging population. This demographic shift highlights a rising proportion of individuals aged 60 years or older compared to other age cohorts within societies. This shift is a consequence of advancements in healthcare, resulting in extended lifespans, declining fertility rates, and transformations in social and economic structures. Anti-aging medications are aimed at extending the healthy lifespan of individuals who display youthful characteristics. For instance, according to the World Health Organization in October 2022, projections indicate that by 2030, one in every six individuals globally will be over 60 years old, marking an increase from 1 billion to 1.4 billion elderly individuals by 2020. Additionally, as per the Eurostat database, individuals aged 65 and above constituted 21.1% of the population, witnessing a 0.3% rise from the previous year and a 3.1% increase from a decade earlier. Hence, the surge in the aging population significantly propels the growth of the anti-aging drugs market.

The expansion of the anti-aging drugs market is expected to be driven by an increase in people's disposable income. This rise in disposable income typically correlates with economic improvements, leading to elevated wages, salaries, and heightened healthcare expenditures. Disposable income plays a pivotal role in influencing the usage of anti-aging drugs, as individuals with higher income levels often possess better accessibility and affordability for these treatments. This accessibility contributes to increased utilization, aiming to preserve a youthful appearance and tackle age-related concerns. For instance, data from the Bureau of Economic Analysis in August 2023 revealed a $7.3 billion rise (less than 0.1%) in disposable personal income and a $144.6 billion increase (0.8%) in personal consumption expenditures (PCE). Thus, the upsurge in people's disposable income significantly drives the growth of the anti-aging drugs market.

Embracing product innovation stands as a significant trend gaining traction within the anti-aging drugs market. Companies within this sector are actively integrating innovative products to fortify their market presence. For example, in April 2023, SkinCeuticals, a US-based leader in advanced skincare, unveiled the corrective cream A.G.E Interrupter Advanced. This product amplifies collagen matrix integrity, featuring a formulation infused with wild fruit flavonoids, glycyrrhetinic acid, and concentrated proxy lane (20% more than the original A.G.E Interrupter). A.G.E. Interrupter Advanced sets itself apart from standard anti-aging products by addressing all stages of the glycation process, rectifying existing signs of aging, and safeguarding against new and recurring damage induced by A.G.E. formation.

Leading companies in the anti-aging drug market are channeling efforts towards the development of cutting-edge skincare solutions aimed at combatting age-related conditions, promoting longevity, and enhancing overall health and well-being. Advanced skincare solutions for anti-aging encompass a spectrum of innovative products and treatments meticulously designed to target and diminish aging signs. These solutions elevate skin health and appearance through the utilization of state-of-the-art technologies and formulations. For instance, in August 2022, NutriGlow Cosmetics Pvt. Ltd., an India-based beauty product provider, introduced a limited-edition line of anti-aging skincare products on their platform. This range includes items such as NutriGlow Advanced Organics Anti Pigmentation Serum, Anti Pigmentation Night Cream, Age Repair Tightening Serum, Age Repair Tightening Day Cream, Vitamin C Skin Lightening Serum, and Vitamin C Skin Lightening Night Cream. These dermatologically-tested anti-aging products are infused with Vitamin C and Hyaluronic Acid, addressing various skin concerns such as dark spots, fine lines, hyperpigmentation, discoloration, and uneven skin tone for consumers.

In July 2021, AbbVie Inc., a US-based pharmaceutical company specializing in the discovery and delivery of innovative medicines, successfully acquired Allergan plc for a total of $63 billion. This strategic acquisition is anticipated to bolster AbbVie's position as a well-diversified leader in crucial therapeutic categories. Allergan plc, also based in the United States, is a pharmaceutical company engaged in the manufacturing of medical aesthetics drugs and medical devices, which includes products related to anti-aging skincare.

Major companies operating in the anti-aging drugs market report are L'Oréal S.A., Galderma S.A., Merz Pharma GmbH & Co. KGaA, Sanofi S.A., Elysium Health Inc., Estée Lauder Companies Inc., AbbVie Inc., La Roche-Posay, Nu Skin Enterprises Inc., Dermafix Biotech Private Limited, The Procter & Gamble Company, Johnson & Johnson Services Inc., Sun Pharmaceutical Industries Ltd., BioTime Inc., PT. Daewoong Pharmaceutical Co. Ltd., Allergan plc, Daewoong Pharmaceutical Co. Ltd., MMJ PhytoTech Limited, Revitacare, SciVision Biotech, Canbex Therapeutics Ltd., Lumenis Ltd., Cynosure Inc., Age Sciences Inc., ALMA LASERS Ltd., Bausch Health Companies Inc., Hansen Supplements, Ponce De Leon Health Inc. , Youth & Earth, Vitality Pro.

North America was the largest region in the anti-aging drugs market in 2023. The regions covered in the anti-aging drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the anti-aging drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary types of anti-aging drugs include serums, creams, gels, and other formulations. Serums are clear, yellowish liquids that remain after blood clotting and removal of blood cells. These drugs fall into various classes, including hormonal therapy, antioxidants, enzymes, stem cells, and others, available in forms such as injectables, oral medications, and topical applications. Various ingredients such as retinoid, hyaluronic acid, alpha hydroxy acid, among others, are applied to the skin and hair, targeting skeletal and muscle health, age-related disorders, and other aspects of the aging process.

The anti-aging drugs market research report provides anti-aging drugs market statistics, including anti-aging drugs industry global market size, regional shares, competitors with a anti-aging drugs market share, detailed anti-aging drugs market segments, market trends and opportunities, and any further data you may need to thrive in the anti-aging drugs industry. This anti-aging drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anti-aging drugs market consists of sales of dermal fillers, botulinum toxin, anti-wrinkle products, and anti-stretch mark products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Anti-Aging Drugs Market Characteristics3. Anti-Aging Drugs Market Trends and Strategies
4. Anti-Aging Drugs Market - Macro Economic Scenario
4.1. Impact of High Inflation on the Market
4.2. Ukraine-Russia War Impact on the Market
4.3. COVID-19 Impact on the Market
5. Global Anti-Aging Drugs Market Size and Growth
5.1. Global Anti-Aging Drugs Market Drivers and Restraints
5.1.1. Drivers of the Market
5.1.2. Restraints of the Market
5.2. Global Anti-Aging Drugs Historic Market Size and Growth, 2018-2023, Value ($ Billion)
5.3. Global Anti-Aging Drugs Forecast Market Size and Growth, 2023-2028, 2033F, Value ($ Billion)
6. Anti-Aging Drugs Market Segmentation
6.1. Global Anti-Aging Drugs Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Serums
  • Creams
  • Gels
  • Other Products
6.2. Global Anti-Aging Drugs Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hormonal Therapy
  • Antioxidants
  • Enzymes
  • Stem Cells
6.3. Global Anti-Aging Drugs Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Injectable
  • Oral
  • Topical
6.4. Global Anti-Aging Drugs Market, Segmentation by Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Retinoid
  • Hyaluronic Acid
  • Alpha Hydroxy Acid
  • Other Ingredients
6.5. Global Anti-Aging Drugs Market, Segmentation by Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Skin and Hair
  • Skeletal and Muscles
  • Age Related Disorders
  • Other Applications
7. Anti-Aging Drugs Market Regional and Country Analysis
7.1. Global Anti-Aging Drugs Market, Split by Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Anti-Aging Drugs Market, Split by Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Anti-Aging Drugs Market
8.1. Asia-Pacific Anti-Aging Drugs Market Overview
  • Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Anti-Aging Drugs Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Anti-Aging Drugs Market, Segmentation by Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Anti-Aging Drugs Market, Segmentation by Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Anti-Aging Drugs Market
9.1. China Anti-Aging Drugs Market Overview
9.2. China Anti-Aging Drugs Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Anti-Aging Drugs Market, Segmentation by Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Anti-Aging Drugs Market, Segmentation by Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Anti-Aging Drugs Market
10.1. India Anti-Aging Drugs Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Anti-Aging Drugs Market, Segmentation by Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Anti-Aging Drugs Market, Segmentation by Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Anti-Aging Drugs Market
11.1. Japan Anti-Aging Drugs Market Overview
11.2. Japan Anti-Aging Drugs Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Anti-Aging Drugs Market, Segmentation by Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Anti-Aging Drugs Market, Segmentation by Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Anti-Aging Drugs Market
12.1. Australia Anti-Aging Drugs Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Anti-Aging Drugs Market, Segmentation by Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Anti-Aging Drugs Market, Segmentation by Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Anti-Aging Drugs Market
13.1. Indonesia Anti-Aging Drugs Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Anti-Aging Drugs Market, Segmentation by Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Anti-Aging Drugs Market, Segmentation by Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Anti-Aging Drugs Market
14.1. South Korea Anti-Aging Drugs Market Overview
14.2. South Korea Anti-Aging Drugs Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Anti-Aging Drugs Market, Segmentation by Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Anti-Aging Drugs Market, Segmentation by Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Anti-Aging Drugs Market
15.1. Western Europe Anti-Aging Drugs Market Overview
15.2. Western Europe Anti-Aging Drugs Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Anti-Aging Drugs Market, Segmentation by Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Anti-Aging Drugs Market, Segmentation by Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Anti-Aging Drugs Market
16.1. UK Anti-Aging Drugs Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Anti-Aging Drugs Market, Segmentation by Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Anti-Aging Drugs Market, Segmentation by Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Anti-Aging Drugs Market
17.1. Germany Anti-Aging Drugs Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Anti-Aging Drugs Market, Segmentation by Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Anti-Aging Drugs Market, Segmentation by Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Anti-Aging Drugs Market
18.1. France Anti-Aging Drugs Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Anti-Aging Drugs Market, Segmentation by Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Anti-Aging Drugs Market, Segmentation by Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Anti-Aging Drugs Market
19.1. Italy Anti-Aging Drugs Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Anti-Aging Drugs Market, Segmentation by Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Anti-Aging Drugs Market, Segmentation by Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Anti-Aging Drugs Market
20.1. Spain Anti-Aging Drugs Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Anti-Aging Drugs Market, Segmentation by Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Anti-Aging Drugs Market, Segmentation by Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Anti-Aging Drugs Market
21.1. Eastern Europe Anti-Aging Drugs Market Overview
21.2. Eastern Europe Anti-Aging Drugs Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Anti-Aging Drugs Market, Segmentation by Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Anti-Aging Drugs Market, Segmentation by Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Anti-Aging Drugs Market
22.1. Russia Anti-Aging Drugs Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Anti-Aging Drugs Market, Segmentation by Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Anti-Aging Drugs Market, Segmentation by Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Anti-Aging Drugs Market
23.1. North America Anti-Aging Drugs Market Overview
23.2. North America Anti-Aging Drugs Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Anti-Aging Drugs Market, Segmentation by Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Anti-Aging Drugs Market, Segmentation by Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Anti-Aging Drugs Market
24.1. USA Anti-Aging Drugs Market Overview
24.2. USA Anti-Aging Drugs Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Anti-Aging Drugs Market, Segmentation by Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Anti-Aging Drugs Market, Segmentation by Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Anti-Aging Drugs Market
25.1. Canada Anti-Aging Drugs Market Overview
25.2. Canada Anti-Aging Drugs Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Anti-Aging Drugs Market, Segmentation by Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Anti-Aging Drugs Market, Segmentation by Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Anti-Aging Drugs Market
26.1. South America Anti-Aging Drugs Market Overview
26.2. South America Anti-Aging Drugs Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Anti-Aging Drugs Market, Segmentation by Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Anti-Aging Drugs Market, Segmentation by Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Anti-Aging Drugs Market
27.1. Brazil Anti-Aging Drugs Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Anti-Aging Drugs Market, Segmentation by Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Anti-Aging Drugs Market, Segmentation by Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Anti-Aging Drugs Market
28.1. Middle East Anti-Aging Drugs Market Overview
28.2. Middle East Anti-Aging Drugs Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Anti-Aging Drugs Market, Segmentation by Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Anti-Aging Drugs Market, Segmentation by Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Anti-Aging Drugs Market
29.1. Africa Anti-Aging Drugs Market Overview
29.2. Africa Anti-Aging Drugs Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Anti-Aging Drugs Market, Segmentation by Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Anti-Aging Drugs Market, Segmentation by Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Anti-Aging Drugs Market Competitive Landscape and Company Profiles
30.1. Anti-Aging Drugs Market Competitive Landscape
30.2. Anti-Aging Drugs Market Company Profiles
30.2.1. L'Oréal S.A.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Galderma S.A.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Merz Pharma GmbH & Co. KGaA
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Sanofi S.A.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Elysium Health Inc.
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Global Anti-Aging Drugs Market Competitive Benchmarking32. Global Anti-Aging Drugs Market Competitive Dashboard33. Key Mergers and Acquisitions in the Anti-Aging Drugs Market
34. Anti-Aging Drugs Market Future Outlook and Potential Analysis
34.1 Anti-Aging Drugs Market in 2028 - Countries Offering Most New Opportunities
34.2 Anti-Aging Drugs Market in 2028 - Segments Offering Most New Opportunities
34.3 Anti-Aging Drugs Market in 2028 - Growth Strategies
34.3.1 Market Trend-based Strategies
34.3.2 Competitor Strategies
35. Appendix
35.1. Abbreviations
35.2. Currencies
35.3. Historic and Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Analyst
35.6. Copyright and Disclaimer

Executive Summary

This report provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anti-aging drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia-Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for anti-aging drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

Markets Covered:
1) By Product: Serums; Creams; Gels; Other Products
2) By Drug Class: Hormonal Therapy; Antioxidants; Enzymes; Stem Cells
3) By Type: Injectable; Oral; Topical
4) By Ingredient: Retinoid; Hyaluronic Acid; Alpha Hydroxy Acid; Other Ingredients
5) By Drug Application: Skin And Hair; Skeletal And Muscles; Age Related Disorders; Other Applications
Companies Mentioned: L'Oréal S.A.; Galderma S.A.; Merz Pharma GmbH & Co. KGaA; Sanofi S.A.; Elysium Health Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes

Delivery Format: PDF, Word and Excel Data Dashboard

Companies Mentioned

  • L'Oréal S.A.
  • Galderma S.A.
  • Merz Pharma GmbH & Co. KGaA
  • Sanofi S.A.
  • Elysium Health Inc.
  • Estée Lauder Companies Inc.
  • AbbVie Inc.
  • La Roche-Posay
  • Nu Skin Enterprises Inc.
  • Dermafix Biotech Private Limited
  • The Procter & Gamble Company
  • Johnson & Johnson Services Inc.
  • Sun Pharmaceutical Industries Ltd.
  • BioTime Inc.
  • PT. Daewoong Pharmaceutical Co. Ltd.
  • Allergan plc
  • Daewoong Pharmaceutical Co. Ltd.
  • MMJ PhytoTech Limited
  • Revitacare
  • SciVision Biotech
  • Canbex Therapeutics Ltd.
  • Lumenis Ltd.
  • Cynosure Inc.
  • Age Sciences Inc.
  • ALMA LASERS Ltd.
  • Bausch Health Companies Inc.
  • Hansen Supplements
  • Ponce De Leon Health Inc.
  • Youth & Earth
  • Vitality Pro

Methodology

Loading
LOADING...